Guardian Therapeutics
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
101 Hartwell Ave Ste 2, Lexington, Massa...Phone Number
(781) 918-6580Website
www.guardiantherapeutics.comRevenue
<$5 MillionIndustry
About Guardian Therapeutics
Guardian Therapeutics is focused on revolutionizing aptamer discovery and engineering drug-like aptamer therapeutics. The company specializes in various therapeutic areas, including hematology, dermatology, gastroenterology, and oncology. Their innovative approach involves a rapid aptamer discovery process utilizing deep sequencing and high-throughput synthesis. Guardian Therapeutics aims to bring to life the full potential of aptamer therapeutics to provide effective solutions in their targeted therapeutic programs.Explore more
Guardian Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Guardian Therapeutics
Compare insights from companies similar to Guardian Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Guardian Therapeutics Tech Stack
A closer look at the technologies used by Guardian Therapeutics
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Guardian Therapeutics
Sign Up For FreeTo access detailed company insights
Guardian Therapeutics is focused on revolutionizing aptamer discovery and engineering drug-like aptamer therapeutics. The company specializes in various therapeutic areas, including hematology, dermatology, gastroenterology, and oncology. Their innovative approach involves a rapid aptamer discovery process utilizing deep sequencing and high-through... Read More
